Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects

Abstract Background Tryptamide (TRP) is an experimental anti-inflammatory and analgesic drug with a favourable safety profile even at high doses. Since neuroinflammation is a significant contributor to the pathogenesis of various neurodegenerative diseases, in this study we screened for the potential direct neuroprotective effect of TRP in comparison to the classical anti-inflammatory compound, ibuprofen (Ibu), in cellular models of Parkinson’s disease. Methods We compared the effectiveness of TRP (1-300 µM) with Ibu (10–300 µM) against cell damage induced by oxidative stress inducers (H 2 O 2 and 6-hydroxydopamine, 6-OHDA), dopaminergic neurotoxin 1-methyl-4-phenylpyridinium ion (MPP(+)), and pro-apoptotic factors, staurosporine (St) and doxorubicin (Dox) in undifferentiated (UN-) and retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. The neuroprotective effects were evidenced by biochemical assays (MTT reduction and LDH release tests), morphology (microscopic evaluation), and caspase-3 activity, as well as validated in mouse primary mesencephalic neurons. Results We demonstrated that TRP and Ibu at concentrations up to 100 µM, when given for 24 and 48 h, did not evoke any detrimental effects in UN- and RA-SH-SY5Y cells, but induced some cytotoxicity at the highest concentration tested (300 µM) in UN-SH-SY5Y cells. TRP significantly attenuated the cytotoxic effect of MPP(+) in UN- and RA-SH-SY5Y cells and was protective against H 2 O 2 , St, and Dox only in differentiated cells, however, it did not attenuate the 6-OHDA-induced cell death in both cell phenotypes. Moreover, the protection of TRP against MPP(+) and St, but not against Dox, was associated with inhibition of caspase-3 activity. Ibu did not show any protection in either of the tested cell models or cell phenotypes, with the exception of minor protection (10 µM) against St in UN-SH-SY5Y cells. The effects of TRP were orthogonally confirmed by high-content imaging of Calcein AM/Hoechst 33,342-stained RA-SH-SY5Y cells exposed to MPP(+) and of tyrosine hydroxylase (TH)-immunostained mouse primary mesencephalic neurons exposed to MPP(+) or 6-OHDA. Conclusions Our results evidenced a neuroprotective potential of TRP against various cell-damaging factors, with its higher effectiveness in RA-SH-SY5Y cells in apoptotic, rather than oxidative stress-based neuronal cell damage models, which was also confirmed in primary mesencephalic neurons. TRP effects on RA-differentiated neurons were further validated by energy metabolism profile and high-content imaging in the MPP(+) model. Thus, TRP has neuroprotective potential, worth further investigation.

Authors

Institutions

Publication Details

Journal
Pharmacological Reports
Published
2026-11-14
DOI
https://doi.org/10.1007/s43440-026-00924-9
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects

Ryszard Bugno, Katarzyna Maziarz, Danuta Jantas, Andrzej Jacek Bojarski et al.
Pharmacological Reports
Parkinson's Disease Mechanisms and Treatments
article

Comparison of the neuroprotective effects of tryptamide and ibuprofen in cellular Parkinson’s disease models: cell damage type- and cell phenotype-dependent effects

Ryszard Bugno, Katarzyna Maziarz, Danuta Jantas, Andrzej Jacek Bojarski, Katarzyna Z. Kuter, Piotr Chmielarz, Agata Maziak, Zuzanna Wilk, Aleksandra Mąsior
article en

Abstract

Abstract Background Tryptamide (TRP) is an experimental anti-inflammatory and analgesic drug with a favourable safety profile even at high doses. Since neuroinflammation is a significant contributor to the pathogenesis of various neurodegenerative diseases, in this study we screened for the potential direct neuroprotective effect of TRP in comparison to the classical anti-inflammatory compound, ibuprofen (Ibu), in cellular models of Parkinson’s disease. Methods We compared the effectiveness of TRP (1-300 µM) with Ibu (10–300 µM) against cell damage induced by oxidative stress inducers (H 2 O 2 and 6-hydroxydopamine, 6-OHDA), dopaminergic neurotoxin 1-methyl-4-phenylpyridinium ion (MPP(+)), and pro-apoptotic factors, staurosporine (St) and doxorubicin (Dox) in undifferentiated (UN-) and retinoic acid (RA)-differentiated human neuroblastoma SH-SY5Y cells. The neuroprotective effects were evidenced by biochemical assays (MTT reduction and LDH release tests), morphology (microscopic evaluation), and caspase-3 activity, as well as validated in mouse primary mesencephalic neurons. Results We demonstrated that TRP and Ibu at concentrations up to 100 µM, when given for 24 and 48 h, did not evoke any detrimental effects in UN- and RA-SH-SY5Y cells, but induced some cytotoxicity at the highest concentration tested (300 µM) in UN-SH-SY5Y cells. TRP significantly attenuated the cytotoxic effect of MPP(+) in UN- and RA-SH-SY5Y cells and was protective against H 2 O 2 , St, and Dox only in differentiated cells, however, it did not attenuate the 6-OHDA-induced cell death in both cell phenotypes. Moreover, the protection of TRP against MPP(+) and St, but not against Dox, was associated with inhibition of caspase-3 activity. Ibu did not show any protection in either of the tested cell models or cell phenotypes, with the exception of minor protection (10 µM) against St in UN-SH-SY5Y cells. The effects of TRP were orthogonally confirmed by high-content imaging of Calcein AM/Hoechst 33,342-stained RA-SH-SY5Y cells exposed to MPP(+) and of tyrosine hydroxylase (TH)-immunostained mouse primary mesencephalic neurons exposed to MPP(+) or 6-OHDA. Conclusions Our results evidenced a neuroprotective potential of TRP against various cell-damaging factors, with its higher effectiveness in RA-SH-SY5Y cells in apoptotic, rather than oxidative stress-based neuronal cell damage models, which was also confirmed in primary mesencephalic neurons. TRP effects on RA-differentiated neurons were further validated by energy metabolism profile and high-content imaging in the MPP(+) model. Thus, TRP has neuroprotective potential, worth further investigation.

Pharmacological Reports
Maj Institute of Pharmacology (PL), Polish Academy of Sciences (PL)
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon